NKTR earnings: a positive outcome, +10.0%

On May 10, 2024, Nektar Therapeutics reached its earnings. The result was a positive outcome, and the stock moved +10.0% in the window around the event. It had already run +16.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.